Biotech M&A spree buoys healthcare dealmakers before US conference
Last month alone, drugmakers including AbbVie, Bristol Myers Squibb and AstraZeneca announced about 25bn worth of transactions
07 January 2024 - 19:20
New York — Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.
Kicking-off on Monday, the four-day JPMorgan Healthcare Conference is expected by organisers to attract more than 8,000 people, including delegations from the world’s largest drugmakers...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.